Health Care: Drugs

Albany Molecular Research Inc. (AMRI: NASDAQ)

$11.03 -0.17 | -1.52%
05/21/13 - 01:45 PM ET
Company Profile
Price and Volume
Recent Price 11.20
52 Week High 12.50
52 Week Low 2.25
Avg. Daily Vol. (Mil) 0.53
Beta (3 year) 2.06
Share Related Items
Mkt Cap (Mil) 351.88
Shares Out (Mil) 31.42
Float (Mil) 23.28
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.10
Current Ratio 3.20
LT Debt/ Equity 0.04
Total Debt / Equity 0.04
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.55
Price/Book 1.71
Price/Cash Flow 26.00
Per Share Data
Earnings -0.12
Sales 7.22
Book Value 6.56
Cash Flow 0.43
Business Summary
Albany Molecular Research, Inc., is a contract research and manufacturing organization providing customers drug discovery, development and manufacturing services.
General Information
26 Corporate Circle
Albany, NY 12203
www.amriglobal.com
Industry : Drugs
Sector: Health Care
Employees: 1329
CEO: Dr. Thomas E. D'Ambra,Ph
Short Interest
Current Month (Mil) 0.97
Previous Month (Mil) 0.64
Short Interest Ratio (Days) 2.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -1.40
Return on Investments -1.80
Profitability
Gross Margin 33.50
EBIT Margin 0.30
Profit Margin -1.70

Portfolios with AMRI

View All

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases

Partner Headlines for AMRI

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter